Arca biopharma announces third quarter 2020 financial results and provides corporate update

Westminster, colo., nov. 02, 2020 (globe newswire) -- arca biopharma, inc. (nasdaq: abio), a biopharmaceutical company applying a precision medicine approach to developing genetically targeted therapies for cardiovascular diseases, today reported financial results for the third quarter of 2020 and provided a corporate update.
ABIO Ratings Summary
ABIO Quant Ranking